1 Scope of the Report 1
1.1 Market Introduction 1
1.2 Years Considered 1
1.3 Research Objectives 2
1.4 Market Research Methodology 2
1.5 Research Process and Data Source 4
1.6 Economic Indicators 5
1.7 Currency Considered 5
2 Executive Summary 6
2.1 World Market Overview 6
2.1.1 Global Generic Drugs Consumption 2016-2026 6
2.1.2 Generic Drugs Consumption CAGR by Region 7
2.2 Generic Drugs Segment by Type 7
2.2.1 Simple Generic Drugs 7
2.2.2 Super Generic Drugs 8
2.2.3 Biosimilars 8
2.3 Generic Drugs Sales by Type 8
2.3.1 Global Generic Drugs Sales Market Share by Type (2016-2021) 8
2.3.2 Global Generic Drugs Revenue and Market Share by Type (2016-2021) 9
2.3.3 Global Generic Drugs Sale Price by Type (2016-2021) 10
2.4 Generic Drugs Segment by Application 10
2.4.1 CNS 10
2.4.2 Cardiovascular 11
2.4.3 Genitourinary/Hormonal Drugs 11
2.4.4 Respiratory 11
2.4.5 Rheumatology 12
2.4.6 Diabetes 12
2.4.7 Oncology 12
2.4.8 Others 12
2.5 Generic Drugs Sales by Application 13
2.5.1 Global Generic Drugs Sale Market Share by Application (2016-2021) 13
2.5.2 Global Generic Drugs Revenue and Market Share by Application (2016-2021) 13
2.5.3 Global Generic Drugs Sale Price by Application (2016-2021) 14
3 Global Generic Drugs by Company 16
3.1 Global Generic Drugs Sales Market Share by Company 16
3.1.1 Global Generic Drugs Sales by Company (2019-2021) 16
3.1.2 Global Generic Drugs Sales Market Share by Company (2019-2021) 16
3.2 Global Generic Drugs Revenue Market Share by Company 18
3.2.1 Global Generic Drugs Revenue by Company (2019-2021) 18
3.2.2 Global Generic Drugs Revenue Market Share by Company (2019-2021) 18
3.3 Global Generic Drugs Sale Price by Company 19
3.4 Key Manufacturers Generic Drugs Producing Area Distribution, Sales Area, Product Type 20
3.4.1 Key Manufacturers Generic Drugs Product Location Distribution 20
3.4.2 Players Generic Drugs Products Offered 21
3.5 Market Concentration Rate Analysis 21
3.5.1 Competition Landscape Analysis 21
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 21
3.6 New Products and Potential Entrants 22
3.7 Mergers & Acquisitions, Expansion 22
4 Generic Drugs by Region 23
4.1 Global Generic Drugs by Region 23
4.1.1 Global Generic Drugs Sales by Region 23
4.1.2 Global Generic Drugs Revenue by Region 23
4.2 Americas Generic Drugs Sales Growth 24
4.3 APAC Generic Drugs Sales Growth 25
4.4 Europe Generic Drugs Sales Growth 25
4.5 Middle East & Africa Generic Drugs Sales Growth 25
5 Americas 27
5.1 Americas Generic Drugs Sales by Country 27
5.1.1 Americas Generic Drugs Sales by Country (2016-2021) 27
5.1.2 Americas Generic Drugs Revenue by Country (2016-2021) 28
5.2 Americas Generic Drugs Sales by Type 28
5.3 Americas Generic Drugs Sales by Application 28
5.4 United States 29
5.5 Canada 29
5.6 Mexico 30
5.7 Brazil 30
6 APAC 31
6.1 APAC Generic Drugs Sales by Region 31
6.1.1 APAC Generic Drugs Sales by Region (2016-2021) 31
6.1.2 APAC Generic Drugs Revenue by Region (2016-2021) 31
6.2 APAC Generic Drugs Sales by Type 32
6.3 APAC Generic Drugs Sales by Application 33
6.4 China 33
6.5 Japan 33
6.6 Korea 33
6.7 Southeast Asia 33
6.8 India 34
6.9 Australia 34
7 Europe 35
7.1 Europe Generic Drugs by Country 35
7.1.1 Europe Generic Drugs Sales by Country (2016-2021) 35
7.1.2 Europe Generic Drugs Revenue by Country (2016-2021) 35
7.2 Europe Generic Drugs Sales by Type 36
7.3 Europe Generic Drugs Sales by Application 36
7.4 Germany 37
7.5 France 37
7.6 UK 37
7.7 Italy 37
7.8 Russia 37
8 Middle East & Africa 38
8.1 Middle East & Africa Generic Drugs by Country 38
8.1.1 Middle East & Africa Generic Drugs Sales by Country (2016-2021) 38
8.1.2 Middle East & Africa Generic Drugs Revenue by Country (2016-2021) 38
8.2 Middle East & Africa Generic Drugs Sales by Type 38
8.3 Middle East & Africa Generic Drugs Sales by Application 39
8.4 Egypt 39
8.5 South Africa 39
8.6 Israel 39
8.7 Turkey 39
8.8 GCC Countries 40
9 Market Drivers, Challenges and Trends 41
9.1 Market Drivers and Impact 41
9.1.1 Growing Demand from Key Regions 41
9.1.2 Growing Demand from Key Application and Potential Industries 41
9.2 Market Challenges and Impact 41
9.3 Market Trends 41
10 Marketing, Distributors and Customer 43
10.1 Sales Channel 43
10.1.1 Direct Channels 43
10.1.2 Indirect Channels 43
10.2 Generic Drugs Distributors 45
10.3 Generic Drugs Customer 46
11 Global Generic Drugs Market Forecast 47
11.1 Global Generic Drugs Forecast by Region 47
11.1.1 Global Generic Drugs Forecast by Region (2021-2026) 47
11.1.2 Global Generic Drugs Revenue Forecast by Region (2021-2026) 47
11.2 Americas Forecast by Country 47
11.3 APAC Forecast by Region 48
11.4 Europe Forecast by Country 48
11.5 Middle East & Africa Forecast by Country 49
11.6 Global Generic Drugs Forecast by Type 50
11.7 Global Generic Drugs Forecast by Application 50
12 Key Players Analysis 52
12.1 Teva 52
12.1.1 Teva Company Information 52
12.1.2 Teva Generic Drugs Product Offered 52
12.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 52
12.1.4 Teva Main Business Overview 53
12.1.5 Teva Latest Developments 53
12.2 Novartis – Sandoz 53
12.2.1 Novartis – Sandoz Company Information 53
12.2.2 Novartis – Sandoz Generic Drugs Product Offered 53
12.2.3 Novartis – Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 54
12.2.4 Novartis – Sandoz Main Business Overview 54
12.2.5 Novartis – Sandoz Latest Developments 54
12.3 Mylan 55
12.3.1 Mylan Company Information 55
12.3.2 Mylan Generic Drugs Product Offered 55
12.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 55
12.3.4 Mylan Main Business Overview 55
12.3.5 Mylan Latest Developments 56
12.4 Sun Pharmaceutical 56
12.4.1 Sun Pharmaceutical Company Information 56
12.4.2 Sun Pharmaceutical Generic Drugs Product Offered 56
12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 57
12.4.4 Sun Pharmaceutical Main Business Overview 57
12.4.5 Sun Pharmaceutical Latest Developments 57
12.5 Aspen 57
12.5.1 Aspen Company Information 57
12.5.2 Aspen Generic Drugs Product Offered 58
12.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 58
12.5.4 Aspen Main Business Overview 58
12.5.5 Aspen Latest Developments 58
12.6 Fresenius Kabi 59
12.6.1 Fresenius Kabi Company Information 59
12.6.2 Fresenius Kabi Generic Drugs Product Offered 59
12.6.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 59
12.6.4 Fresenius Kabi Main Business Overview 60
12.6.5 Fresenius Kabi Latest Developments 60
12.7 Pfizer (Hospira) 60
12.7.1 Pfizer (Hospira) Company Information 60
12.7.2 Pfizer (Hospira) Generic Drugs Product Offered 60
12.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 61
12.7.4 Pfizer (Hospira) Main Business Overview 61
12.7.5 Pfizer (Hospira) Latest Developments 61
12.8 Sanofi 62
12.8.1 Sanofi Company Information 62
12.8.2 Sanofi Generic Drugs Product Offered 62
12.8.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 62
12.8.4 Sanofi Main Business Overview 62
12.8.5 Sanofi Latest Developments 63
12.9 Aurobindo 63
12.9.1 Aurobindo Company Information 63
12.9.2 Aurobindo Generic Drugs Product Offered 63
12.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 64
12.9.4 Aurobindo Main Business Overview 64
12.9.5 Aurobindo Latest Developments 64
12.10 Lupin 64
12.10.1 Lupin Company Information 64
12.10.2 Lupin Generic Drugs Product Offered 65
12.10.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 65
12.10.4 Lupin Main Business Overview 65
12.10.5 Lupin Latest Developments 65
12.11 Dr. Reddy’s 66
12.11.1 Dr. Reddy’s Company Information 66
12.11.2 Dr. Reddy’s Generic Drugs Product Offered 66
12.11.3 Dr. Reddy’s Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 66
12.11.4 Dr. Reddy’s Main Business Overview 67
12.11.5 Dr. Reddy’s Latest Developments 67
12.12 Apotex 67
12.12.1 Apotex Company Information 67
12.12.2 Apotex Generic Drugs Product Offered 68
12.12.3 Apotex Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 68
12.12.4 Apotex Main Business Overview 68
12.12.5 Apotex Latest Developments 68
12.13 Cipla 69
12.13.1 Cipla Company Information 69
12.13.2 Cipla Generic Drugs Product Offered 69
12.13.3 Cipla Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 69
12.13.4 Cipla Main Business Overview 69
12.13.5 Cipla Latest Developments 70
12.14 ENDO (Par Pharmaceutical) 70
12.14.1 ENDO (Par Pharmaceutical) Company Information 70
12.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Offered 70
12.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Revenue, Price and Gross Margin
(2019-2021) 71
12.14.4 ENDO (Par Pharmaceutical) Main Business Overview 71
12.14.5 ENDO (Par Pharmaceutical) Latest Developments 71
12.15 Stada Arzneimittel 71
12.15.1 Stada Arzneimittel Company Information 71
12.15.2 Stada Arzneimittel Generic Drugs Product Offered 72
12.15.3 Stada Arzneimittel Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 72
12.15.4 Stada Arzneimittel Main Business Overview 72
12.15.5 Stada Arzneimittel Latest Developments 73
12.16 Krka Group 73
12.16.1 Krka Group Company Information 73
12.16.2 Krka Group Generic Drugs Product Offered 73
12.16.3 Krka Group Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 74
12.16.4 Krka Group Main Business Overview 74
12.16.5 Krka Group Latest Developments 74
12.17 Nichi-Iko Pharmaceutical 74
12.17.1 Nichi-Iko Pharmaceutical Company Information 74
12.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Offered 75
12.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin
(2019-2021) 75
12.17.4 Nichi-Iko Pharmaceutical Main Business Overview 75
12.17.5 Nichi-Iko Pharmaceutical Latest Developments 76
12.18 Valeant 76
12.18.1 Valeant Company Information 76
12.18.2 Valeant Generic Drugs Product Offered 76
12.18.3 Valeant Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 76
12.18.4 Valeant Main Business Overview 77
12.18.5 Valeant Latest Developments 77
12.19 Zydus Cadila 77
12.19.1 Zydus Cadila Company Information 77
12.19.2 Zydus Cadila Generic Drugs Product Offered 78
12.19.3 Zydus Cadila Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 78
12.19.4 Zydus Cadila Main Business Overview 78
12.19.5 Zydus Cadila Latest Developments 78
12.20 Hikma 79
12.20.1 Hikma Company Information 79
12.20.2 Hikma Generic Drugs Product Offered 79
12.20.3 Hikma Generic Drugs Sales, Revenue, Price and Gross Margin (2019-2021) 79
12.20.4 Hikma Main Business Overview 79
12.20.5 Hikma Latest Developments 80
13 Research Findings and Conclusion 81
ジェネリック医薬品の世界市場 |
| 【英語タイトル】Global Generic Drugs Market Growth 2021-2026 | |
 | ・商品コード：WR-057944 ・発行会社（調査会社）：LP Information ・発行日：2021年3月（※2024年版があります。お問い合わせください。） ・ページ数：113 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル ・産業分野：医薬品 |
| Single User（1名様閲覧用） | USD3,660 ⇒換算￥534,360 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,490 ⇒換算￥801,540 | 見積依頼/購入/質問フォーム |
| Global License（法人閲覧用） | USD7,320 ⇒換算￥1,068,720 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
to this latest study, the 2021 growth of Generic Drugs will have significant change from previous year. By the most conservative estimates of global Generic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Generic Drugs market will register a xx CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Simple Generic Drugs
Super Generic Drugs
Biosimilars
Segmentation by Application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Teva
Novartis – Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy’s
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
❖ レポートの目次 ❖
| ★調査レポート[ジェネリック医薬品の世界市場] (コード：WR-057944)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[ジェネリック医薬品の世界市場]についてメールでお問い合わせ |
